eCite Digital Repository
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?
Citation
Aboy, M and Crespo, C and Liddell, K and Liddicoat, J and Jordan, M, Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?, Nature Biotechnology, 36, (12) pp. 1146-1149. ISSN 1087-0156 (2018) [Refereed Article]
Copyright Statement
Copyright © 2018, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
Official URL: https://www.nature.com/articles/nbt.4308
DOI: doi:10.1038/nbt.4308
Abstract
Five years later, what are the wider impacts of the US Supreme Court's Myriad decision on subject-matter eligibility and patent prosecution for nature-based products beyond isolated DNA?
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | patent law, DNA, Myriad, USA |
| Research Division: | Law and Legal Studies |
| Research Group: | Law in context |
| Research Field: | Law, science and technology |
| Objective Division: | Law, Politics and Community Services |
| Objective Group: | Justice and the law |
| Objective Field: | Legislation, civil and criminal codes |
| UTAS Author: | Liddicoat, J (Mr John Liddicoat) |
| ID Code: | 145065 |
| Year Published: | 2018 |
| Web of Science® Times Cited: | 10 |
| Deposited By: | Office of the Faculty of Law |
| Deposited On: | 2021-06-29 |
| Last Modified: | 2021-09-09 |
| Downloads: | 0 |
Repository Staff Only: item control page